Pharming Group reports financial results for the first half of 2022
Pharming Group N.V. presents its preliminary (unaudited) financial report for the first six months of 2022 ended June 30, 2022.
The Company held an analyst conference call on August 4, 2022 at 13.30 CET/07.30 EST.
To launch the audio webcast recording of the call please click on this link.
Presentation slides and a transcript of the call can be downloaded below.
"Pharming delivered strong half year results with total revenues up 4% compared to the same period last year. RUCONEST® sales growth was supported by increases in physicians prescribing and number of patients."- Sijmen de Vries | Chief Executive Officer